Rituxan Shows Sustained Benefit For RA In Phase II Trials
Friday October 31, 2003
Results from Phase II clinical trials for Rituxan were announced by Genentech, IDEC Pharmaceuticals, and Roche, at the 2003 American College of Rheumatology meeting in Orlando, Florida. The news ... Read More